Clinical Trials
30 trialsTherapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Kedrion S.p.A.
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
APEX
Cogent Biosciences, Inc.
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
inMMyCAR
Kelonia Therapeutics, Inc.
Autologous Testicular Tissue Transplantation
Universitair Ziekenhuis Brussel
BRUIN-CLL-314
Eli Lilly and Company
QUATRO-APL
Quetzal Therapeutics
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
University of Southern California
HORIZONS
Massachusetts General Hospital
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
CTL-DP 01
Nantes University Hospital
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Adults With T-allo10 Cells Addback
Stanford University
IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia
Zhejiang University
CD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALL
University of Colorado, Denver
BMT-CARE
Massachusetts General Hospital
HEME Home Transfusion Program
Dana-Farber Cancer Institute
CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases
Zhejiang University
TREG108
Cellenkos, Inc.
Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization
University Hospital Bispebjerg and Frederiksberg
TECTONIC
Universitaire Ziekenhuizen KU Leuven
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Vincerx Pharma, Inc.
BCMA-GPRC5D CAR-T Therapy in Relapsed or Refractory Multiple Myeloma
Shenzhen University General Hospital
Myeloproliferative Neoplasms (MPNs) Patient Registry
University Health Network, Toronto
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
OriCell Therapeutics Co., Ltd.
Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology
Meyer Children's Hospital IRCCS
A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma
Hellenic Society of Hematology
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen Inc